Clinical Trials for Azacitidine

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCPED1365
04/16/2014
T2011-002: A Phase I Study of 5-Azacytidine in Combination with Chemotherapy for Children with Relapsed or Refractory ALL or AML
TreatmentVICCHEM1294
02/25/2013
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Subjects with Acute Myeloid Leukemia in Complete Remission
TreatmentVICCTHN1242
10/24/2012
A Phase IB, Multi-Center,Open-Label Study of the MTOR Kinase Inhibitor CC-223 in Combination with Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.